×
BiomX Long Term Debt 2019-2024 | PHGE
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Total Assets
Cash on Hand
Long Term Debt
Total Liabilities
Share Holder Equity
BiomX long term debt from 2019 to 2024. Long term debt can be defined as the sum of all long term debt fields.
View More
Related Stocks
Company Name
Market
Cap
Abbott Laboratories (ABT)
$199.1B
Stryker (SYK)
$138.5B
Boston Scientific (BSX)
$123.7B
Medtronic (MDT)
$116.1B
EssilorLuxottica (ESLOY)
$106.2B
Lonza Group Ag (LZAGY)
$44.7B
Haleon (HLN)
$44.4B
ResMed (RMD)
$35.7B
Terumo (TRUMY)
$28.9B
Koninklijke Philips (PHG)
$24.7B
Zimmer Biomet Holdings (ZBH)
$22.4B
Baxter (BAX)
$18.3B
Insulet (PODD)
$16.2B
Smith & Nephew SNATS (SNN)
$12.6B
Bio-Rad Laboratories (BIO)
$9.2B
BellRing Brands (BRBR)
$8.6B
Demant (WILYY)
$8.4B
Lantheus Holdings (LNTH)
$7.6B
ICU Medical (ICUI)
$4.3B
TG Therapeutics (TGTX)
$3.9B
Haemonetics (HAE)
$3.7B
Prestige Consumer Healthcare (PBH)
$3.6B
Perrigo (PRGO)
$3.5B
Envista Holdings (NVST)
$3.3B
Neogen (NEOG)
$3.2B
GN Store Nord (GNNDY)
$2.9B
Agios Pharmaceuticals (AGIO)
$2.6B
QuidelOrtho (QDEL)
$2.6B
Green Thumb Industries (GTBIF)
$2.1B
LeMaitre Vascular (LMAT)
$2B
BiomX Long Term Debt 2019-2024 | PHGE
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Total Assets
Cash on Hand
Long Term Debt
Total Liabilities
Share Holder Equity
BiomX long term debt from 2019 to 2024. Long term debt can be defined as the sum of all long term debt fields.
Related Stocks
Company Name
Market Cap
Abbott Laboratories (ABT)
$199.1B
Stryker (SYK)
$138.5B
Boston Scientific (BSX)
$123.7B
Medtronic (MDT)
$116.1B
EssilorLuxottica (ESLOY)
$106.2B
Lonza Group Ag (LZAGY)
$44.7B
Haleon (HLN)
$44.4B
ResMed (RMD)
$35.7B
Terumo (TRUMY)
$28.9B
Koninklijke Philips (PHG)
$24.7B
Zimmer Biomet Holdings (ZBH)
$22.4B
Baxter (BAX)
$18.3B
Insulet (PODD)
$16.2B
Smith & Nephew SNATS (SNN)
$12.6B
Bio-Rad Laboratories (BIO)
$9.2B
BellRing Brands (BRBR)
$8.6B
Demant (WILYY)
$8.4B
Lantheus Holdings (LNTH)
$7.6B
ICU Medical (ICUI)
$4.3B
TG Therapeutics (TGTX)
$3.9B
Haemonetics (HAE)
$3.7B
Prestige Consumer Healthcare (PBH)
$3.6B
Perrigo (PRGO)
$3.5B
Envista Holdings (NVST)
$3.3B
Neogen (NEOG)
$3.2B
GN Store Nord (GNNDY)
$2.9B
Agios Pharmaceuticals (AGIO)
$2.6B
QuidelOrtho (QDEL)
$2.6B
Green Thumb Industries (GTBIF)
$2.1B
LeMaitre Vascular (LMAT)
$2B